NYKODE THERAPEUTICS ASA (NYKD.OL) Stock Earnings & Estimates
Europe - Euronext Oslo - OSL:NYKD - NO0010714785 - Common Stock
2.64 NOK
+0.17 (+6.97%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.168M -78.89% | 12.902M 79.99% | 8.679M -32.73% | 1.02M | -100.00% | 13.26M | 4.217M -68.20% | 705.78M 16,636.54% | 2.537B 259.46% | 5.998B 136.42% | |
| EBITDA YoY % growth | -48.85M -598.76% | -54.237M -11.03% | -44.88M 17.25% | -29.07M | -26.52M 8.77% | -19.89M 25.00% | -177.091M -790.35% | -596.779M -236.99% | 942.33M 257.90% | 2.647B 180.90% | |
| EBIT YoY % growth | -50.664M -555.84% | -56.359M -11.24% | -47.131M 16.37% | -29.07M | -27.03M 7.02% | -21.93M 18.87% | -265.637M -1,111.29% | -668.349M -151.60% | -35.235M 94.73% | 2.555B 7,351.41% | |
| Operating Margin | -706.81% | -436.82% | -543.05% | -2,850.00% | N/A | -165.38% | -6,299.18% | -94.70% | -1.39% | 42.60% | |
| EPS YoY % growth | N/A -1,364.33% | -0.12 19.66% | -0.12 -0.18% | -0.03 | -0.08 -166.67% | -0.05 37.50% | -1.05 -1,967.00% | -1.54 -46.19% | -0.11 92.86% | 3.78 3,536.70% |
Reported data in USD, estimates in NOK
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.02 -0.10% | -0.03 | 0.01 | 34.64% |
| Q3 2024 Q2Q % growth | -0.03 -0.10% | -0.04 | 0.01 | 32.12% |
| Q2 2024 Q2Q % growth | -0.02 33.18% | -0.06 | 0.04 | 68.68% |
| Q1 2024 Q2Q % growth | -0.05 -25.31% | -0.05 | 0.00 | 2.04% |
| Q4 2023 Q2Q % growth | -0.02 49.94% | -0.05 | 0.03 | 59.71% |
| Q3 2023 Q2Q % growth | -0.03 | -0.05 | 0.02 | 44.54% |
| Q2 2023 Q2Q % growth | -0.03 | -0.05 | 0.02 | 41.17% |
| Q1 2023 Q2Q % growth | -0.04 | -0.05 | 0.01 | 21.64% |
| Q4 2022 Q2Q % growth | -0.04 | -0.04 | 0.00 | 1.94% |
Reported revenue can not be compared with estimates as they are in different currencies. Reported data is in USD, while estimates are NOK.
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 6.894M -70.90% | 1.462M | 5.432M | 371.55% |
| Q3 2024 Q2Q % growth | 536K -98.15% | 3.162M | -2.626M | -83.05% |
| Q2 2024 Q2Q % growth | 544K -98.98% | 3.11M | -2.566M | -82.51% |
| Q1 2024 Q2Q % growth | 827.04K -97.41% | 68.84M | -68.013M | -98.80% |
| Q4 2023 Q2Q % growth | 23.689M 780.63% | 2.074M | 21.615M | 1,042.19% |
| Q3 2023 Q2Q % growth | 28.921M 4,363.12% | 2.055M | 26.866M | 1,307.35% |
| Q2 2023 Q2Q % growth | 53.505M 1,618.21% | 1.02M | 52.485M | 5,145.59% |
| Q1 2023 Q2Q % growth | 31.987M 4,373.71% | 1.02M | 30.967M | 3,035.98% |
| Q4 2022 Q2Q % growth | 2.69M -91.30% | 1.02M | 1.67M | 163.73% |
| Q3 2022 Q2Q % growth | 648K -35.26% | % | ||
| Q2 2022 Q2Q % growth | 3.114M 93.66% | % | ||
| Q1 2022 Q2Q % growth | 715K 60.31% | % | ||
| Q4 2021 Q2Q % growth | 30.908M -85.62% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | 0% | 45.45% |
| Revenue | N/A | N/A | 0% | 100% |